Ghent University Academic Bibliography

Advanced

Blood-brain barrier and ADME properties of selected DALDA-peptide derivatives

Sylvia Van Dorpe UGent, Evelien Wynendaele UGent, Christian Burvenich UGent, Alexandre Novoa, Dirk Tourwé, Steven Ballet and Bart De Spiegeleer UGent (2011) Farmaceutische Wetenschappen, 15e Forum, Samenvattingen.
abstract
Most naturally occurring opioid peptides, such as the endomorphins, are not highly selective for a single opioid receptor type. However, it was observed that dermorphins show a very high µ-opioid receptor selectivity compared to most other natural peptides. The 3+ charged tetrapeptide Dmt-DALDA (Dmt-D-Arg-Phe-Lys-NH2), an analogue of the µ-selective dermorphin, is of particular interest since it has been identified as a more potent μ-opioid receptor agonist compared to dermorphin [1]. The present study describes the blood-brain barrier (BBB) transport behaviour of some related Dmt-DALDA analogues as well as their ADME properties. The influx transfer constant from serum into mouse brain was determined by multiple time regression while the efflux kinetics were investigated with the intracerebroventricular injection technique. Brain parenchyma-capillary cell distribution was evaluated by capillary depletion. In addition, the functional drugability of these µ- opioid peptides was evaluated using our desirability criterion [2]. The obtained experimental data indicate that: i) BBB influx requires the guanidine group of D-Arg, with the presence of the ε-amino group of Lys of lesser importance; ii) BBB efflux is only observed if the guanidine group of D-Arg is oxidised to D-citrulline; iii) a higher BBB drugability of the Dmt-DALDA analogues compared to dermorphin was objectively calculated by the desirability criterion values; iv) replacing the ε-amino group of D-Arg with a methyl group, while retaining the guanidine group, yielded a peculiar liver uptake of the peptide. References: [1] P. Riba, Y. Ben, T.M.D. Nguyen, S. Furst, P.W. Schiller and N.M. Lee. [Dmt(1)]DALDA is highly selective and potent at mu opioid receptors, but is not cross-tolerant with systemic morphine, Current Medicinal Chemistry 9(1) (2002) 31-39. [2] S. Van Dorpe, A. Adriaens, S. Vermeire, I. Polis, K. Peremans and B. De Spiegeleer. Desirability function combining metabolic stability and functionality of peptides, Journal of Peptide Science (2011) doi 10.1002/psc.1323.
Please use this url to cite or link to this publication:
author
organization
year
type
conference
publication status
published
subject
in
Farmaceutische Wetenschappen, 15e Forum, Samenvattingen
conference name
15e Forum der Farmaceutische Wetenschappen (BGFW 2011)
conference location
Spa, Belgium
conference start
2011-05-12
conference end
2011-05-13
language
English
UGent publication?
yes
classification
C3
additional info
oral presentation; uploaded document is presentation
copyright statement
I have retained and own the full copyright for this publication
id
1235433
handle
http://hdl.handle.net/1854/LU-1235433
date created
2011-05-25 08:48:56
date last changed
2013-04-29 11:11:03
@inproceedings{1235433,
  abstract     = {Most naturally occurring opioid peptides, such as the endomorphins, are not highly selective for a single opioid receptor type. However, it was observed that dermorphins show a very high {\textmu}-opioid receptor selectivity compared to most other natural peptides. The 3+ charged tetrapeptide Dmt-DALDA (Dmt-D-Arg-Phe-Lys-NH2), an analogue of the {\textmu}-selective dermorphin, is of particular interest since it has been identified as a more potent \ensuremath{\mu}-opioid receptor agonist compared to dermorphin [1]. The present study describes the blood-brain barrier (BBB) transport behaviour of some related Dmt-DALDA analogues as well as their ADME properties. The influx transfer constant from serum into mouse brain was determined by multiple time regression while the efflux kinetics were investigated with the intracerebroventricular injection technique. Brain parenchyma-capillary cell distribution was evaluated by capillary depletion. In addition, the functional drugability of these {\textmu}- opioid peptides was evaluated using our desirability criterion [2]. The obtained experimental data indicate that: i) BBB influx requires the guanidine group of D-Arg, with the presence of the \ensuremath{\epsilon}-amino group of Lys of lesser importance; ii) BBB efflux is only observed if the guanidine group of D-Arg is oxidised to D-citrulline; iii) a higher BBB drugability of the Dmt-DALDA analogues compared to dermorphin was objectively calculated by the desirability criterion values; iv) replacing the \ensuremath{\epsilon}-amino group of D-Arg with a methyl group, while retaining the guanidine group, yielded a peculiar liver uptake of the peptide. References: [1]\unmatched{0009}P. Riba, Y. Ben, T.M.D. Nguyen, S. Furst, P.W. Schiller and N.M. Lee. [Dmt(1)]DALDA is highly selective and potent at mu opioid receptors, but is not cross-tolerant with systemic morphine, Current Medicinal Chemistry 9(1) (2002) 31-39. [2]\unmatched{0009}S. Van Dorpe, A. Adriaens, S. Vermeire, I. Polis, K. Peremans and B. De Spiegeleer. Desirability function combining metabolic stability and functionality of peptides, Journal of Peptide Science (2011) doi 10.1002/psc.1323.},
  author       = {Van Dorpe, Sylvia and Wynendaele, Evelien and Burvenich, Christian and Novoa, Alexandre and Tourw{\'e}, Dirk and Ballet, Steven and De Spiegeleer, Bart},
  booktitle    = {Farmaceutische Wetenschappen, 15e Forum, Samenvattingen},
  language     = {eng},
  location     = {Spa, Belgium},
  title        = {Blood-brain barrier and ADME properties of selected DALDA-peptide derivatives},
  year         = {2011},
}

Chicago
Van Dorpe, Sylvia, Evelien Wynendaele, Christian Burvenich, Alexandre Novoa, Dirk Tourwé, Steven Ballet, and Bart De Spiegeleer. 2011. “Blood-brain Barrier and ADME Properties of Selected DALDA-peptide Derivatives.” In Farmaceutische Wetenschappen, 15e Forum, Samenvattingen.
APA
Van Dorpe, S., Wynendaele, E., Burvenich, C., Novoa, A., Tourwé, D., Ballet, S., & De Spiegeleer, B. (2011). Blood-brain barrier and ADME properties of selected DALDA-peptide derivatives. Farmaceutische Wetenschappen, 15e Forum, Samenvattingen. Presented at the 15e Forum der Farmaceutische Wetenschappen (BGFW 2011).
Vancouver
1.
Van Dorpe S, Wynendaele E, Burvenich C, Novoa A, Tourwé D, Ballet S, et al. Blood-brain barrier and ADME properties of selected DALDA-peptide derivatives. Farmaceutische Wetenschappen, 15e Forum, Samenvattingen. 2011.
MLA
Van Dorpe, Sylvia, Evelien Wynendaele, Christian Burvenich, et al. “Blood-brain Barrier and ADME Properties of Selected DALDA-peptide Derivatives.” Farmaceutische Wetenschappen, 15e Forum, Samenvattingen. 2011. Print.